Company: EVGN
Filing Date: 2025-03-27
Form Type: 20-F
Source: 0001178913-25-001092
Chunk: 163

Company: Evogene Ltd.
Filing Date: 2025-03-27
Form: 20-F
Item: Item 4A
Chunk 163
---
 options to purchase shares of Biomica. For a description  
           of our subsidiaries’ equity incentive plans, please see “ Item 6. Directors, Senior Management and Employees— B. Compensation— Share         
           Option and Incentive Plans— Subsidiary Equity Incentive Plans”.                                                                              
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

  (4)      Consists of 16,250 ordinary shares issuable upon exercise of options that are currently exercisable or exercisable within 60 days            
           of March 17, 2025, of which options to purchase the following number of shares expire on the following dates, respectively: 3,000 on August  
           8, 2027, 750 on July 30, 2029, 7,000 on September 1, 2031, 3,000 on March 8, 2033 and 2,500 on November 20, 2034. The weighted average       
           exercise price of these options is NIS 81.36 per ordinary share.                                                                             
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

96

  (5)      Consists of 15,500 ordinary shares issuable upon exercise of options that are currently exercisable or exercisable within 60 days            
           of March 17, 2025, of which options to purchase the following number of shares expire on the following dates, respectively: 1,000 on August  
           10, 2026, 250 on August 8, 2027,250 on August 6, 2028, 250 on September 23, 2029, 250 on September 22, 2030, 3,600 on September 1, 2031,     
           3,600 on September 15, 2032, 3,600 on May 11, 2033 and 2,700 on June 13, 2034. The weighted average exercise price of these options is       
           NIS 63.12 per ordinary share.                                                                                                                
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

  (6)      Consists of 4,950 ordinary shares issuable upon exercise of options that are currently exercisable or exercisable within 60 days